| Ytd | 67.51% | |
| 1y | 36.55% |
| Open | 48.54 | Prev Close | 49.36 | Low | 47.88 | High | 49.66 | Mkt Cap | 4.23B |
| Vol | 68.64K | Avg Vol | 1.79M | EPS | -0.24 | P/E | N/A | Forward P/E | -191.84 |
| Beta | 2.73 | Short Ratio | 2.59 | Inst. Own | 91.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 43.61 | 200-d Avg | 32.20 | 1yr Est | 46.00 |
HTFL News
Heartflow, Inc. (NASDAQ: HTFL - Get Free Report)'s stock price hit a new 52-week high on Monday. The
Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raise
UBS analyst Doug Schenkel initiates coverage on HeartFlow (NASDAQ:HTFL) with a Neutral rating and
HeartFlow shares are surging Friday after it reported better-than-expected Q2 adjusted EPS results a
Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raise
Morgan Stanley analyst Patrick Wood maintains HeartFlow (NASDAQ:HTFL) with a Equal-Weight and rai
Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular
Piper Sandler analyst Matt OBrien reiterates HeartFlow (NASDAQ:HTFL) with a Overweight and raises
JP Morgan analyst Robbie Marcus maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raises th
Wells Fargo analyst Larry Biegelsen maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raise
U.S. stocks up, Dow Jones 0.1% higher. HeartFlow (HTFL) shares rise 26.5% on better-than-expected ea
Stifel analyst Rick Wise maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target
Gainers Capricor Therapeutics (NASDAQ:CAPR) stock rose 94.8% to $8.2 during Friday's pre-market
Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results
HeartFlow (NASDAQ:HTFL) released second-quarter financial results and hosted an earnings call on Thu
Gainers Akanda (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session
HeartFlow (NASDAQ:HTFL) reported quarterly losses of $(0.07) per share which beat the analyst consen
HeartFlow (NASDAQ:HTFL) raises FY2026 sales outlook from $218.000 million-$222.000 million to $246.0
Wall Street analysts changed outlook on top names. Check ratings page for upgrades, downgrades, init
Baird analyst David Rescott initiates coverage on HeartFlow (NASDAQ:HTFL) with a Outperform ratin
Freedom Capital Markets analyst Gene Mannheimer initiates coverage on HeartFlow (NASDAQ:HTFL) wit
Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and lower
Wells Fargo analyst Larry Biegelsen maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raise
HeartFlow (NASDAQ:HTFL) raises FY2026 sales outlook from $218.000 million-$222.000 million to $228.0
HeartFlow (NASDAQ:HTFL) reported quarterly losses of $(0.16) per share which beat the analyst consen
Options markets are pricing post-earnings moves between 17.74% and 42.50% on ten small/mid caps repo
Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease
JP Morgan analyst Robbie Marcus maintains HeartFlow (NASDAQ:HTFL) with a Overweight and lowers th
Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raise
U.S. stocks drop, with Dow Jones down 150 points. Signet Jewelers stock rose 11.8% after beating ear
Wells Fargo analyst Larry Biegelsen maintains HeartFlow (NASDAQ:HTFL) with a Overweight and lower
HeartFlow (NASDAQ:HTFL) sees FY2026 sales of $218.000 million-$222.000 million vs $212.899 million a
HeartFlow (NASDAQ:HTFL) reported quarterly losses of $(0.12) per share which beat the analyst consen
